Rafferty Asset Management, LLC Aerie Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $95,998 - $166,805	-17,021 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$7.02 - $13.33 $119,487 - $226,889	17,021 New	17,021 $119,000
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $155,210 - $334,541	-13,109 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$17.72 - $25.1 $8,310 - $11,771	-469 Reduced 3.45%	13,109 $317,000
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $249,970 - $380,184	13,578 New	13,578 $261,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.